Skip to main content
. 2021 Apr 17;10(8):1746. doi: 10.3390/jcm10081746

Table 1.

Patient characteristics.

Patient Characteristics Mean ± Standard Deviation (Extremes) or n (%)
(N = 200)
Age at diagnosis (years) 62.72 ± 9.19 (27–83)
BMI (kg/m2) 27.90 ± 6.31 (15.43–50.17)
Score ASA 3
1 15 (7.50)
2 15 (7.50)
3 14 (7.00)
NR 1 72 (36.00)
Initial histological type
Endometrioid 96 (48.00)
Clear cells 16 (8.00)
Papillary serous 44 (22.00)
Carcinosarcoma 26 (13.00)
Poorly differentiated 16 (8.00)
In situ 1 (0.50)
Hyperplasia with atypia 1 (0.50)
Initial grade
1 25 (12.50)
2 48 (24.00)
3 108 (54.00)
NR 19 (9.50)
Initial stage 2
IA 37 (18.50)
IB 34 (17.00)
II 15 (7.50)
IIIA 10 (5.00)
IIIB 3 (1.50)
IIIC1 37 (18.50)
IIIC2 59 (29.50)
IVA 2 (1.00)
IVB 3 (1.50)
Initial indication for PAL 4
At diagnosis 149 (74.50)
After hysterectomy results 42 (21.00)
After positive pelvic lymph node finding 9 (4.50)

1 NR: not reported, 2 Stage evaluated by MRI and/or FDG-PET/CT, 3 ASA: American Society of Anesthesiologists, 4 PAL: Para-Aortic Lymphadenectomy.